UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction (LEPHT)
    KellyAnn Light-McGroary
  2. A randomized double-blinded phase III study comparing gemcitabine, cisplatin, and bevacizumab (IND #113911, NSC #704865) to gemcitabine, cisplatin, and placebo in patients with advanced transitional c…
    Daniel Vaena
  3. High-Frequency OAEs and Ototoxicity
    Shawn Goodman
  4. SynCardia CardioWest TAH-t Postmarket Surveillance Study
    Jennifer Goerbig-Campbell
  5. RTOG 1010: A phase III trial evaluating the addition of trastuzumab to trimodality treatment of HER2-overexpressing esophageal adenocarinoma
    Mark C. Smith
  6. A randomized double-blinded phase III study comparing gemcitabine, cisplatin, and bevacizumab (IND #7921, NSC #704865) to gemcitabine, cisplatin, and placebo in patients with advanced transitional cel…
    Daniel Vaena
  7. A randomized double-blind, placebo-controlled study of LEE011 in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive, HER2-negative, advanced breast can…
    Alexandra Thomas
  8. Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program (PAH QuERI Ext)
    Linda Cadaret
  9. Safety Study of Ambrisentan in Subjects With Pulmonary Hypertension
    Alicia Gerke
  10. A Phase I Trial of a Ketogenic Diet with Concurrent Chemoradiation for Pancreatic Cancer
    Sudershan Bhatia
  11. Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
    Ayman El-Sheikh
  12. A Phase I Trial of a Ketogenic Diet with Concurrent Chemoradiation for Non-Small Cell Lung Cancer
    Sudershan Bhatia
  13. A Phase 3, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Double-blind Study to Evaluate the Efficacy and Safety of Telotristat Etiprate (LX1606) in Patients with Carcinoid Syndrome Refr…
    Joseph Dillon
  14. Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy®) in Patients with Metastatic Melanoma
    Mohammed Milhem
  15. A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Th
    Daniel Vaena
  16. Study to Compare Cancer Treating Drugs
    Mohammed Milhem
  17. Molecular Pathways in Cardiovascular Disease
    Frances Johnson
  18. A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endome…
    David Bender
  19. Randomized Controlled Study Comparing AEZS-108 with Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer
    David Bender
  20. A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following Fir…
    David Bender

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.